Letters to the Editor
Vol. 96 No. 3 (2026)
https://doi.org/10.4081/monaldi.2025.3396

Beyond breathlessness: unveiling chronic cough in interstitial lung diseases. A pilot Portuguese cohort

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 30 January 2025
Accepted: 9 April 2025
Published: 26 May 2025
730
Views
462
Downloads
Prevalence, cough, profile, assessment, management

Authors

Flávia Ferreira
Lab3R – Respiratory Research and Rehabilitation Laboratory, School of Health Sciences, University of Aveiro, Portugal.
Ana Machado
https://orcid.org/0000-0002-4427-2695
Lab3R – Respiratory Research and Rehabilitation Laboratory, School of Health Sciences, University of Aveiro; Department of Medical Sciences, iBiMED – Institute of Biomedicine, University of Aveiro, Portugal.
Vânia Fernandes
https://orcid.org/0000-0002-2534-6767
Pulmonology Department, Local Health Unit of the Aveiro Region (ULSRA), Aveiro, Portugal.
Tiago Alfaro
https://orcid.org/0000-0001-6490-0620
Pulmonology Department, Local Health Unit of Coimbra (ULS Coimbra), Portugal.
Alda Marques
Lab3R – Respiratory Research and Rehabilitation Laboratory, School of Health Sciences, University of Aveiro; Department of Medical Sciences, iBiMED – Institute of Biomedicine, University of Aveiro, Portugal.
Ana Oliveira
alao@ua.pt
https://orcid.org/0000-0003-4516-6904
Lab3R – Respiratory Research and Rehabilitation Laboratory, School of Health Sciences, University of Aveiro, Portugal; Department of Medical Sciences, iBiMED – Institute of Biomedicine, University of Aveiro, Portugal; School of Rehabilitation Sciences, McMaster University, Hamilton, Canada.

Dear Editor,
Chronic cough, lasting at least 8 weeks, is a prevalent symptom in individuals with interstitial lung disease, posing significant physical, psychological, and social challenges...

Downloads

Download data is not yet available.

Lan NSH, Moore I, Lake F. Understanding cough in interstitial lung disease: a cross‐sectional study on the adequacy of treatment. Intern Med J 2021;51:923-9. DOI: https://doi.org/10.1111/imj.14837

Abozid H, Patel J, Burney P, et al. Prevalence of chronic cough, its risk factors and population attributable risk in the Burden of Obstructive Lung Disease (BOLD) study: a multinational cross-sectional study. EClinicalMedicine 2024;68:102423. DOI: https://doi.org/10.1016/j.eclinm.2024.102423

Martins PC, Caires I, Almeida I, et al. Prevalence and risk factors of chronic cough in an adult community-dwelling Portuguese population. ERJ Open Res 2025;93:00887-2024. DOI: https://doi.org/10.1183/23120541.00887-2024

Ethics Approval

Ethical approval was obtained from two committees [Centro Hospitalar e Universitário de Coimbra (No476/CES; No OBS.SF.150-2022) and University of Aveiro (52-CED/2022)].

CRediT authorship contribution

Flávia Ferreira, Ana Machado, Ana Oliveira, Alda Marques: study concept and design, verification of the work and the questionnaires. Flávia Ferreira, Vânia Fernandes, Tiago Alfaro: survey’s dissemination, acquisition of data and critical review of the manuscript and manuscript editing. Flávia Ferreira: data collection and data analysis. Alda Marques, Ana Oliveira: supervision. All authors contributed to the writing of the manuscript, critically revised the manuscript, ensured the accuracy and integrity of the work and approved the final version to be published.

How to Cite



Ferreira, Flávia, Ana Machado, Vânia Fernandes, Tiago Alfaro, Alda Marques, and Ana Oliveira. 2025. “Beyond Breathlessness: Unveiling Chronic Cough in Interstitial Lung Diseases. A Pilot Portuguese Cohort”. Monaldi Archives for Chest Disease 96 (3). https://doi.org/10.4081/monaldi.2025.3396.
Copyright (c) 2025 The Author(s) Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.